Showing results (71-80 of 851) with videos related to
Sort By:
Pageof 86
Pathology International|November 7, 2020
Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese populationJunichiro Sato, Kotaro Azuma, Keiichi Kinowaki, et al.Frontiers in Oncology|November 22, 2021
Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell CarcinomaShuhei Kamada, Kazuhiro Ikeda, Takashi Suzuki, et al.Pathology International|February 12, 2025
Combined use of immunoreactivities of Efp and ZCCHC3 for predicting prognosis of patients with triple-negative breast cancerAkihiro Fujimoto, Kazuhiro Ikeda, Keiichi Kinowaki, et al.International Journal of Cancer|June 13, 2019
ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progressionTakeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie-Inoue, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 21, 2015
Osteoblast-Specific γ-Glutamyl Carboxylase-Deficient Mice Display Enhanced Bone Formation With Aberrant MineralizationKotaro Azuma, Sachiko Shiba, Tomoka Hasegawa, et al.The Journal of Steroid Biochemistry and Molecular Biology|October 2, 2010
Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancerNobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, et al.Plos One|October 7, 2014
Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathwayYojiro Maruyama, Toshiaki Miyazaki, Kazuhiro Ikeda, et al.International Journal of Cancer|June 8, 2011
ARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migrationDaisuke Obinata, Ken-ichi Takayama, Tomohiko Urano, et al.Clinical Genitourinary Cancer|February 14, 2016
Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate CancerTetsuya Fujimura, Satoshi Inoue, Tomohiko Urano, et al.Biochemical and Biophysical Research Communications|April 11, 2009
TRIM44 interacts with and stabilizes terf, a TRIM ubiquitin E3 ligaseTomohiko Urano, Takahiko Usui, Shizu Takeda, et al.Pageof 86